title: Abnormal nuclear envelopes in the striatum and motor deficits in DYT11 myoclonus-dystonia mouse models.
abstract: DYT11 myoclonus-dystonia (M-D) is a movement disorder characterized by myoclonic jerks with dystonic symptoms and caused by mutations in paternally expressed SGCE, which codes for ε-sarcoglycan. Paternally inherited Sgce heterozygous knock-out (KO) mice exhibit motor deficits and spontaneous myoclonus. Abnormal nuclear envelopes have been reported in cellular and mouse models of early-onset DYT1 generalized torsion dystonia; however, the relationship between the abnormal nuclear envelopes and motor symptoms are not clear. Furthermore, it is not known whether abnormal nuclear envelope exists in non-DYT1 dystonia. In the present study, abnormal nuclear envelopes in the striatal medium spiny neurons (MSNs) were found in Sgce KO mice. To analyze whether the loss of ε-sarcoglycan in the striatum alone causes abnormal nuclear envelopes, motor deficits or myoclonus, we produced paternally inherited striatum-specific Sgce conditional KO (Sgce sKO) mice and analyzed their phenotypes. Sgce sKO mice exhibited motor deficits in both beam-walking and accelerated rotarod tests, while they did not exhibit abnormal nuclear envelopes, alteration in locomotion, or myoclonus. The results suggest that the loss of ε-sarcoglycan in the striatum contributes to motor deficits, while it alone does not produce abnormal nuclear envelopes or myoclonus. Development of therapies targeting the striatum to compensate for the loss of ε-sarcoglycan function may rescue the motor deficits in DYT11 M-D patients.
authors.affiliation: Department of Neurology, College of Medicine, University of Florida, Gainesville, FL 32610-0236, USA.
authors.forename: Fumiaki
authors.initials: F
authors.lastname: Yokoi
authors.forename: Mai T
authors.initials: MT
authors.lastname: Dang
authors.forename: Tong
authors.initials: T
authors.lastname: Zhou
authors.forename: Yuqing
authors.initials: Y
authors.lastname: Li
mesh_terms: D000818:Animals; D004195:Disease Models, Animal; D020821:Dystonic Disorders / Q000145:classification / Q000235:genetics / Q000473:pathology* / Q000503:physiopathology*; D005260:Female; D008124:Locomotion; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D017072:Neostriatum / Q000473:pathology*; D009685:Nuclear Envelope / Q000378:metabolism / Q000473:pathology*; D010641:Phenotype; D011596:Psychomotor Disorders / Q000235:genetics / Q000503:physiopathology*; D049031:Sarcoglycans / Q000172:deficiency / Q000235:genetics*
chemical_list: D049031:Sarcoglycans
references.citation: Proc Natl Acad Sci U S A. 2010 May 25;107(21):9861-6
references.pmid: 20457914
references.citation: Mov Disord. 2008 Apr 15;23(5):761-4
references.pmid: 18265016
references.citation: Eur J Hum Genet. 2003 Feb;11(2):138-44
references.pmid: 12634861
references.citation: Nucleic Acids Res. 1995 Dec 25;23(24):5080-1
references.pmid: 8559668
references.citation: Mol Cell Biol. 2000 May;20(9):3308-15
references.pmid: 10757814
references.citation: Genesis. 2000 Nov-Dec;28(3-4):106-10
references.pmid: 11105051
references.citation: Mov Disord. 2009 Mar 15;24(4):479-89
references.pmid: 19117361
references.citation: Exp Neurol. 2009 Apr;216(2):300-5
references.pmid: 19118553
references.citation: Am J Hum Genet. 2002 Dec;71(6):1303-11
references.pmid: 12444570
references.citation: Proc Natl Acad Sci U S A. 2004 Jan 20;101(3):847-52
references.pmid: 14711988
references.citation: Muscle Nerve. 1998 Apr;21(4):421-38
references.pmid: 9533777
references.citation: Ann Neurol. 2004 Aug;56(2):283-6
references.pmid: 15293281
references.citation: Curr Opin Neurol. 2000 Oct;13(5):533-9
references.pmid: 11073359
references.citation: Exp Cell Res. 2006 Jul 1;312(11):2083-92
references.pmid: 16635485
references.citation: J Biochem. 2010 Oct;148(4):459-66
references.pmid: 20627944
references.citation: Nat Rev Neurosci. 2008 Mar;9(3):222-34
references.pmid: 18285800
references.citation: Cell Tissue Res. 2004 Oct;318(1):121-34
references.pmid: 15338272
references.citation: J Cell Sci. 2008 Oct 15;121(Pt 20):3476-86
references.pmid: 18827015
references.citation: Brain Res. 2002 May 24;937(1-2):32-40
references.pmid: 12020859
references.citation: Mov Disord. 2003 Sep;18(9):1047-51
references.pmid: 14502674
references.citation: J Neurol. 2006 Dec;253 Suppl 7:VII7-13
references.pmid: 17131231
references.citation: Proc Natl Acad Sci U S A. 2004 May 18;101(20):7612-7
references.pmid: 15136718
references.citation: Expert Rev Mol Med. 2009 Sep 28;11:e28
references.pmid: 19781108
references.citation: Curr Biol. 2002 Mar 19;12(6):R197-9
references.pmid: 11909544
references.citation: Mov Disord. 2008 Oct 30;23(14):2055-61
references.pmid: 18759341
references.citation: Hum Mol Genet. 2011 Dec 1;20(23):4644-54
references.pmid: 21890494
references.citation: FEBS Lett. 2005 Aug 29;579(21):4822-8
references.pmid: 16099459
references.citation: Lancet Neurol. 2004 Oct;3(10):598-607
references.pmid: 15380156
references.citation: Behav Brain Res. 2011 Jan 20;216(2):659-65
references.pmid: 20850480
references.citation: Proc Natl Acad Sci U S A. 1988 Jul;85(14):5166-70
references.pmid: 2839833
references.citation: Neuron. 2005 Dec 22;48(6):923-32
references.pmid: 16364897
references.citation: Neurobiol Dis. 2010 Jun;38(3):434-45
references.pmid: 20227500
references.citation: J Neurosci. 2004 Mar 17;24(11):2593-601
references.pmid: 15028751
references.citation: Mov Disord. 2011 May;26(6):1127-33
references.pmid: 21626556
references.citation: Eur J Nucl Med Mol Imaging. 2009 Feb;36(2):269-74
references.pmid: 18719906
references.citation: Adv Neurol. 1988;50:1-8
references.pmid: 3041755
references.citation: Brain Res Mol Brain Res. 2003 Nov 26;119(2):132-43
references.pmid: 14625080
references.citation: Eur J Hum Genet. 2011 Apr;19(4):438-44
references.pmid: 21157498
references.citation: Mov Disord. 2007 Apr 30;22(6):888-92
references.pmid: 17274032
references.citation: Neurology. 2004 Apr 13;62(7):1229-31
references.pmid: 15079037
references.citation: Neurology. 2008 Mar 25;70(13):1010-6
references.pmid: 18362280
references.citation: Neurology. 2002 Aug 13;59(3):445-8
references.pmid: 12177384
references.citation: Neuropathol Appl Neurobiol. 2004 Apr;30(2):91-105
references.pmid: 15043707
references.citation: Chang Gung Med J. 2009 Jan-Feb;32(1):1-11
references.pmid: 19292934
references.citation: Lancet Neurol. 2008 Mar;7(3):207-15
references.pmid: 18243799
references.citation: Proc Natl Acad Sci U S A. 2006 Oct 10;103(41):15254-9
references.pmid: 17015831
references.citation: Neuroscience. 2002;114(4):1005-17
references.pmid: 12379255
references.citation: Neurosci Res. 2006 Dec;56(4):470-4
references.pmid: 17046090
references.citation: Brain Res Mol Brain Res. 2004 Jun 18;125(1-2):1-12
references.pmid: 15193417
references.citation: PLoS One. 2011;6(9):e24539
references.pmid: 21931745
references.citation: Neurobiol Dis. 2007 Aug;27(2):190-206
references.pmid: 17601741
references.citation: J Biochem. 2008 Jan;143(1):39-47
references.pmid: 17956903
references.citation: FEBS Lett. 1998 Jan 23;422(1):27-32
references.pmid: 9475163
references.citation: Annu Rev Neurosci. 2001;24:1-29
references.pmid: 11283303
references.citation: Nat Rev Neurol. 2010 Jan;6(1):29-37
references.pmid: 20057497
references.citation: Nat Genet. 2009 Mar;41(3):286-8
references.pmid: 19182804
references.citation: Biochem Biophys Res Commun. 2004 Jul 23;320(2):606-14
references.pmid: 15219872
references.citation: J Biochem. 2006 Jul;140(1):141-6
references.pmid: 16815860
references.citation: Exp Neurol. 2005 Dec;196(2):452-63
references.pmid: 16242683
references.citation: Nat Genet. 2001 Sep;29(1):66-9
references.pmid: 11528394
references.citation: Hum Mol Genet. 2002 Sep 1;11(18):2147-54
references.pmid: 12189167
references.citation: J Biol Chem. 1997 Dec 19;272(51):32534-8
references.pmid: 9405466
references.citation: Neurosci Res. 2009 Nov;65(3):228-35
references.pmid: 19619587